Holen Sie sich die Stockscreener-App
1.185
0.83%
-0.015
Schlusskurs vom Vortag:
$1.20
Offen:
$1.2
24-Stunden-Volumen:
351.88K
Relative Volume:
0.27
Marktkapitalisierung:
$452.66M
Einnahmen:
$106.34M
Nettoeinkommen (Verlust:
$-74.66M
KGV:
-1.2474
EPS:
-0.95
Netto-Cashflow:
$-46.12M
1W Leistung:
-9.85%
1M Leistung:
-11.19%
6M Leistung:
-0.83%
1J Leistung:
-40.20%
1-Tages-Spanne:
$1.18
$1.225
1-Wochen-Bereich:
$1.12
$1.34
52-Wochen-Spanne:
$0.92
$2.32
Standard Biotools Inc Stock (LAB) Company Profile
Firmenname
Standard Biotools Inc
Sektor
Branche
Telefon
(650) 266-6000
Adresse
2 TOWER PLACE, SOUTH SAN FRANCISCO
Vergleichen Sie LAB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
1.185 | 458.39M | 106.34M | -74.66M | -46.12M | -0.95 |
|
ABT
Abbott Laboratories
|
122.52 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.12 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
355.50 | 136.23B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
89.11 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
80.50 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-13 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-02-27 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-04-16 | Eingeleitet | TD Cowen | Buy |
| 2024-04-04 | Eingeleitet | Jefferies | Buy |
| 2023-07-12 | Eingeleitet | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc Aktie (LAB) Neueste Nachrichten
Earnings To Watch: Standard BioTools Inc (LAB) Reports Q3 2025 R - GuruFocus
Understanding Standard BioTools Inc.’s price movementIPO Watch & Target Return Focused Picks - newser.com
How Standard BioTools Inc. stock performs in interest rate cyclesQuarterly Profit Report & Reliable Intraday Trade Alerts - newser.com
Why Standard BioTools Inc. (FLB) stock is upgraded to buyBuy Signal & Momentum Based Trading Signals - newser.com
Analyzing net buyer seller activity in Standard BioTools Inc.July 2025 Sector Moves & Free Community Supported Trade Ideas - newser.com
Can momentum traders help lift Standard BioTools Inc.Earnings Risk Summary & AI Forecast for Swing Trade Picks - newser.com
Top chart patterns to watch in Standard BioTools Inc.Buy Signal & Low Drawdown Trading Strategies - newser.com
Is Mahasagar Travels Limited Stock a Core Holding or a Speculative PlayCup and Handle Formations & Technical + Fundamental = Smarter Investing - earlytimes.in
Standard BioTools Inc. recovery potential after sell off2025 Geopolitical Influence & Long Hold Capital Preservation Plans - newser.com
Why Standard BioTools Inc. (FLB) stock gets analyst attentionWeekly Earnings Recap & Stepwise Swing Trade Plans - newser.com
Is Standard BioTools Inc. stock cheap compared to fundamentalsQuarterly Portfolio Review & Risk Controlled Daily Plans - newser.com
Standard BioTools (NASDAQ:LAB) Stock Price Down 6.7%Time to Sell? - MarketBeat
Standard BioTools' (LAB) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
Finanzdaten der Standard Biotools Inc-Aktie (LAB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):